… -2 at baseline correlate with poor clinical outcomes in patients treated with FOLFIRI3-b … -
bevacizumab was a manageable option in first line metastatic colorectal cancer patients. Indeed…

… clinical outcomes in mCRC patients. The aim of this study was to retrospectively analyze
clinical outcomes in mCRC patients … metastatic colorectal cancer (mCRC) treated with first-line …

… are the preferred first-line option in treatment of hypertension … of severe hypertension in
patients with colorectal cancer. … shown that bevacizumab-induced hypertension is related to …

… Currently, the standard first-line treatment of metastatic colorectal cancer in Canada is either
a … The increased expression of VEGF has been correlated with metastasis, recurrence, and …

… monoclonal antibody against vascular endothelial growth … as first-line treatment of metastatic
colorectal cancer (CRC) … does not seem to correlate with hypertension and the role of …

… There were 2813 cases in the present study, including 1391 cases treated with bevacizumab
plus CT and 1422 cases treated with single CT. The follow-up time in the present study was …

… However, in this study, for patients receiving bevacizumab in first line, median OS was … ,
several domains of CGA were demonstrated to correlate with oncological outcomes. Therefore, …

… agents (bevacizumab and cetuximab); … clinical safety of first-line bevacizumab and
cetuximab-based chemotherapy in unresectable RAS wild-type metastatic colorectal cancer patients …

… Surprisingly, we found no correlation between blood pressure and … that in phase 3 trials
using bevacizumab in the first line (7.6 months in our cohort … MAP Mean arterial blood pressure …

… Spearman correlation coefficients were calculated between … Patients receiving bevacizumab
as first line treatment (n = 9) … Arterial hypertension is a candidate prognostic biomarker of …